Is Right Sleeve Lower Lobectomy Necessary? Is It Safe?Funding The author(s) received no financial support for the research, authorship, and/or publication of this article.
13 December 2017
01 March 2018
23 May 2018 (online)
Objectives The right sleeve lower lobectomy is the least used of the bronchial sleeve operations. There are only case-based studies in the literature. In this study, we compared this technique to those used in patients who underwent a right lower bilobectomy.
Methods We retrospectively reviewed the data of patients who had been operated on due to non-small cell lung cancer (NSCLC) from January 2005 to December 2015 from a dataset that was formed prospectively. Of the 4,166 patients who underwent resections due to NSCLC, the files of those who had a right sleeve lower lobectomy (group S) and those who had a right lower bilobectomy (group B) were evaluated. The remaining 25 patients in group B and 18 patients in group S were compared in terms of demographic data, morbidity, hospitalization time, mortality, histopathology, recurrence, and total survival.
Results No significant differences in the demographic or clinical characteristics were observed between the two groups, except that group S had more female patients. Postoperative complications developed in 52% of the patients in group B and 11.1% of the patients in group S (p = 0.006). Mean hospitalization time was 9.6 ± 3.6 (range, 6–19) days in group B and 6.72 ± 1.5 (range, 4–9) days in group S (p = 0.001). All patients received complete resections. The mean patient follow-up time was 42.9 months. No significant difference was found between local and distant recurrences (p = 1, p = 0.432). Mean survival time was 89.6 months (5-year rate = 73%), which was 90.6 months (5-year rate = 75.3%) in group B and 63.1 months (5-year rate = 69.3%) in group S (p = 0.82).
Conclusion This technique allows for reduced filling of the thoracic cavity by a prolonged air leak and a reduced prevalence of complications. Additionally, the hospitalization time is shortened. It does not produce any additional mortality burden, and total survival and oncological outcomes are reliable. This technique can be used in selected patients at experienced centers.
- 1 Thomas CP. Conservative resection of the bronchial tree. J R Coll Surg Edinb 1956; 1 (03) 169-186
- 2 Fadel E, Yildizeli B, Chapelier AR, Dicenta I, Mussot S, Dartevelle PG. Sleeve lobectomy for bronchogenic cancers: factors affecting survival. Ann Thorac Surg 2002; 74 (03) 851-858 , discussion 858–859
- 3 Takeda S, Maeda H, Koma M. , et al. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience. Eur J Cardiothorac Surg 2006; 29 (03) 276-280
- 4 Okada M, Yamagishi H, Satake S. , et al. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg 2000; 119 (4 Pt 1): 814-819
- 5 Deslauriers J, Grégoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. Ann Thorac Surg 2004; 77 (04) 1152-1156 , discussion 1156
- 6 Gaissert HA, Mathisen DJ, Moncure AC, Hilgenberg AD, Grillo HC, Wain JC. Survival and function after sleeve lobectomy for lung cancer. J Thorac Cardiovasc Surg 1996; 111 (05) 948-953
- 7 Boudaya M-S, Abid W, Mlika M. Sleeve right lower lobectomy: a rarely performed extended resection. Indian J Surg 2016; 78 (01) 74-76
- 8 Shi W, Zhang W, Sun H, Shao Y. Sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a meta-analysis. World J Surg Oncol 2012; 10 (01) 265
- 9 Galetta D, Solli P, Borri A. , et al. Bilobectomy for lung cancer: analysis of indications, postoperative results, and long-term outcomes. Ann Thorac Surg 2012; 93 (01) 251-257 , discussion 257–258
- 10 Thomas PA, Falcoz P-E, Bernard A. , et al. EPITHOR group. Bilobectomy for lung cancer: contemporary national early morbidity and mortality outcomes. Eur J Cardiothorac Surg 2016; 49 (02) e38-e43 , discussion e43
- 11 Kim AW, Faber LP, Warren WH, Shah ND, Basu S, Liptay MJ. Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival. J Thorac Cardiovasc Surg 2010; 139 (03) 606-611
- 12 Gómez-Caro A, Garcia S, Reguart N. , et al. Determining the appropriate sleeve lobectomy versus pneumonectomy ratio in central non-small cell lung cancer patients: an audit of an aggressive policy of pneumonectomy avoidance. Eur J Cardiothorac Surg 2011; 39 (03) 352-359
- 13 Ludwig C, Morand P, Schnell J, Stoelben E. Preserving middle lobe to improve lung function in non-small-cell lung cancer. Asian Cardiovasc Thorac Ann 2009; 17 (02) 153-156
- 14 Metin M, Sayar A, Demir A. , et al. Sleeve resections: techniques of anastomoses, morbidity, mortality. Turkish J Thorac Cardiovasc Surg 2001; 9 (03) 160-162
- 15 Ma Z, Dong A, Fan J, Cheng H. Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysis. Eur J Cardiothorac Surg 2007; 32 (01) 20-28
- 16 Park JS, Yang HC, Kim HK. , et al. Sleeve lobectomy as an alternative procedure to pneumonectomy for non-small cell lung cancer. J Thorac Oncol 2010; 5 (04) 517-520